Patient Registry Software Global Market Report 2024

Patient registry software is a structured system designed for gathering non-clinical or clinical patient data to evaluate specific outcomes using observational study methodologies.

The main types of products in patient registry software include integrated software and standalone software. The various types of databases include disease registries, health service registries, and product registries. Disease registries focus on a specific disease or condition as the inclusion criterion, serving as a unique database that includes data on individuals diagnosed with a particular disease type. Different deployment models are available, including on-premise and cloud-based solutions, with functionalities encompassing population health management, patient care management, medical research and clinical studies, health information exchange, point-of-care services, and product outcome evaluation. Patient registry software is employed by various entities, including government organizations and third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, as well as research centers.

The patient registry software market research report is one of a series of new reports that provides patient registry software market statistics, including patient registry software industry global market size, regional shares, competitors with patient registry software market share, detailed patient registry software market segments, market trends and opportunities, and any further data you may need to thrive in the patient registry software industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The patient registry software market size has grown rapidly in recent years. It will grow from $2.13 billion in 2023 to $2.44 billion in 2024 at a compound annual growth rate (CAGR) of 14.8%. The expansion observed in the historical period can be attributed to several factors, including increased research and clinical trials in healthcare, government initiatives aimed at tracking and managing diseases, the adoption of electronic health records (EHRs), a rise in the prevalence of chronic diseases, and the growing demand for quality reporting and performance measurement in healthcare.

The patient registry software market size is expected to see rapid growth in the next few years. It will grow to $4.35 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The anticipated growth in the forecast period can be attributed to several factors, including the integration of big data and artificial intelligence (AI) in healthcare research, the generation of real-world evidence, the integration of genomic and precision medicine data, the adoption of mobile and cloud-based registry solutions, and regulatory requirements for data collection in healthcare. Major trends expected in the forecast period encompass patient-driven data collection, the integration of wearables and IoT (Internet of Things) devices, a focus on data interoperability and standardization, the use of blockchain for secure data sharing, and the integration of telehealth and remote monitoring solutions.

The patient registry software market is poised for growth, thanks to the increasing adoption of electronic medical records (EMRs). Electronic medical records, the digital counterparts of paper charts, offer various functionalities, including billing, inter-practice referrals, appointment scheduling, and medication refills. Patient registry software functionality, often integrated as an add-on in EMR and EHR products, is thereby being promoted, contributing to the expansion of the patient registry software market. As of 2021, data from the Organization for Economic Co-operation and Development (OECD), a UK-based intergovernmental organization, revealed that 93% of primary care practices across 24 OECD countries use EMRs, indicating a widespread adoption that is expected to drive the growth of the patient registry software market.

The upward trend in utilizing telehealth services is anticipated to further propel the patient registry software market in the coming years. Telehealth involves the use of digital information and communications technology for remote communication in clinical medical treatment, health-related education, and public health. Patient registry software becomes a valuable tool in telemedicine, aiding in the management of chronic illnesses, supporting clinical research, and enhancing population health management by providing healthcare practitioners with access to patient data. Notably, as of August 2022, the Australian Digital Health Agency reported that over 95,000 practitioners utilized telehealth services, providing 118.2 million telehealth services to 18 million patients from March 2020 to July 2022. This increasing reliance on telehealth services is a significant driver behind the growth of the patient registry software market.

The prominent trend is the emphasis on product innovation. Major companies in this sector are actively developing new product innovations to bolster their market positions. For example, in January 2022, Seqster PDM, Inc., a U.S.-based healthcare company specializing in comprehensive patient records, partnered with the National Pancreas Foundation to create registry software that collects data using remote monitoring devices. This collaboration leverages Seqster's technology to combine patient information from wearable/remote monitoring devices, genomic DNA tests, and EHR in real-time, facilitating more comprehensive and coordinated care. The National Pancreas Foundation (NPCF), a non-profit organization providing support for those affected by pancreatic cancer, is actively involved in this initiative.

Major companies in the patient registry software market are actively developing innovative products, including contact registries, to better serve their existing consumers. Contact registries, which store contact details for specific groups of individuals, serve various purposes, such as emergency management, clinical trial patient recruitment, and disease surveillance. For instance, in March 2022, the Rare Diseases Clinical Research Network, a non-profit organization supported by the National Institutes of Health (NIH), introduced a contact registry to connect patients with rare diseases to researchers, enhancing rare disease research. This registry, managed by the Rare Diseases Clinical Research Network (RDCRN), aims to keep participants informed about available research opportunities while gathering and storing their contact details.

In June 2021, MRO Corp., a U.S.-based software company, acquired FIGmd for an undisclosed amount, signaling a strategic move to enhance its ability to efficiently acquire, ingest, manage, and exchange clinical information across multiple sources and formats for actionable insights. FIGmd, an India-based software company, specializes in assisting healthcare organizations in measuring, assessing, and improving clinical quality data.

Major companies operating in the patient registry software market include Armus Digital Pvt. Ltd., Dacima Software Inc., Evado Clinical, Global Vision Technology Co. Ltd., Gz Technology Pvt. Ltd., Healthmonix LLC, Imagetrend Inc., QVIA Holdings Inc., Lumedx Healthcare Technologies Private Limited, M2s Industries Private Limited, Mckesson Corporation, Opentext Corporation, Optum Health & Technology Private Limited, Phytel Inc., Premier Inc., Syneos Health Inc., Telligen Inc., Advarra Inc., Advera Health Analytics, ArborMetrix Inc., EResearch Technology, FIGmd Inc., Flatiron Health Inc., Healex Systems Ltd., IFA Systems AG, Liaison Technologies Inc., Medrio Inc., Molecular Corp., OM1 Inc., Open Registry, Orion Health Corp., PatientCrossroads, PatientRegistry

North America was the largest region in the patient registry software market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient registry software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the patient registry software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The patient registry software market consists of sales of software and services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.